DK1763374T3 - Pasta, der hærder in situ, dens fremstilling og anvendelse - Google Patents
Pasta, der hærder in situ, dens fremstilling og anvendelseInfo
- Publication number
- DK1763374T3 DK1763374T3 DK05751734.4T DK05751734T DK1763374T3 DK 1763374 T3 DK1763374 T3 DK 1763374T3 DK 05751734 T DK05751734 T DK 05751734T DK 1763374 T3 DK1763374 T3 DK 1763374T3
- Authority
- DK
- Denmark
- Prior art keywords
- pasta
- hardens
- situ
- preparation
- application
- Prior art date
Links
- 238000011065 in-situ storage Methods 0.000 title 1
- 235000015927 pasta Nutrition 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L27/46—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with phosphorus-containing inorganic fillers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L27/446—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L27/48—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with macromolecular fillers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/502—Plasticizers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/46—Special tools for implanting artificial joints
- A61F2/4601—Special tools for implanting artificial joints for introducing bone substitute, for implanting bone graft implants or for compacting them in the bone cavity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
- A61F2002/2817—Bone stimulation by chemical reactions or by osteogenic or biological products for enhancing ossification, e.g. by bone morphogenetic or morphogenic proteins [BMP] or by transforming growth factors [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
- A61F2002/3006—Properties of materials and coating materials
- A61F2002/30062—(bio)absorbable, biodegradable, bioerodable, (bio)resorbable, resorptive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30535—Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30581—Special structural features of bone or joint prostheses not otherwise provided for having a pocket filled with fluid, e.g. liquid
- A61F2002/30583—Special structural features of bone or joint prostheses not otherwise provided for having a pocket filled with fluid, e.g. liquid filled with hardenable fluid, e.g. curable in-situ
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30756—Cartilage endoprostheses
- A61F2002/30766—Scaffolds for cartilage ingrowth and regeneration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0004—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0085—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof hardenable in situ, e.g. epoxy resins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00179—Ceramics or ceramic-like structures
- A61F2310/00293—Ceramics or ceramic-like structures containing a phosphorus-containing compound, e.g. apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/25—Peptides having up to 20 amino acids in a defined sequence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A61L2300/414—Growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/43—Hormones, e.g. dexamethasone
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Composite Materials (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04013668A EP1604693A1 (en) | 2004-06-09 | 2004-06-09 | In situ forming scaffold, its manufacturing and use |
| PCT/EP2005/006204 WO2005120595A2 (en) | 2004-06-09 | 2005-06-09 | In situ hardening paste, its manufacture and use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1763374T3 true DK1763374T3 (da) | 2012-09-24 |
Family
ID=34925319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK05751734.4T DK1763374T3 (da) | 2004-06-09 | 2005-06-09 | Pasta, der hærder in situ, dens fremstilling og anvendelse |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20090048145A1 (da) |
| EP (3) | EP1604693A1 (da) |
| JP (1) | JP4644252B2 (da) |
| CA (1) | CA2569744C (da) |
| DK (1) | DK1763374T3 (da) |
| ES (2) | ES2385212T3 (da) |
| PL (1) | PL1763374T3 (da) |
| PT (1) | PT1763374E (da) |
| WO (1) | WO2005120595A2 (da) |
Families Citing this family (68)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040260398A1 (en) * | 2003-02-10 | 2004-12-23 | Kelman David C. | Resorbable devices |
| US7955616B2 (en) | 2003-09-23 | 2011-06-07 | Orthocon, Inc. | Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects |
| GB0329654D0 (en) * | 2003-12-23 | 2004-01-28 | Smith & Nephew | Tunable segmented polyacetal |
| US8128696B2 (en) * | 2005-05-11 | 2012-03-06 | Hermann Mayr | System and implant for ligament reconstruction or bone reconstruction |
| JP2009504929A (ja) * | 2005-08-18 | 2009-02-05 | スミス アンド ネフュー ピーエルシー | 高強度デバイス及び複合材料 |
| US8852638B2 (en) | 2005-09-30 | 2014-10-07 | Durect Corporation | Sustained release small molecule drug formulation |
| AU2006326271B2 (en) * | 2005-12-14 | 2011-02-24 | Scil Technology Gmbh | A moldable biomaterial for bone regeneration |
| EP1872807A1 (en) | 2006-06-30 | 2008-01-02 | Scil Technology GmbH | Biomaterial containing degradation stabilized polymer |
| JP2008035981A (ja) * | 2006-08-03 | 2008-02-21 | Gc Corp | ペースト状骨補填材 |
| DE102006037362B3 (de) * | 2006-08-09 | 2007-09-20 | Heraeus Kulzer Gmbh | Knochenersatzmaterial |
| GB0618963D0 (en) * | 2006-09-26 | 2006-11-08 | Ucl Business Plc | Formulations and composites with reactive fillers |
| CN102940878A (zh) * | 2006-10-06 | 2013-02-27 | Scil技术股份有限公司 | 脊柱髓核植入物 |
| US8722783B2 (en) * | 2006-11-30 | 2014-05-13 | Smith & Nephew, Inc. | Fiber reinforced composite material |
| AU2007234612B2 (en) | 2006-12-14 | 2013-06-27 | Johnson & Johnson Regenerative Therapeutics, Llc | Protein stabilization formulations |
| CN100427152C (zh) * | 2006-12-26 | 2008-10-22 | 四川国纳科技有限公司 | 多孔类骨磷灰石/聚酰胺复合材料的制备方法 |
| EP2142353A1 (en) | 2007-04-18 | 2010-01-13 | Smith & Nephew PLC | Expansion moulding of shape memory polymers |
| JP5520814B2 (ja) | 2007-04-19 | 2014-06-11 | スミス アンド ネフュー インコーポレーテッド | マルチモーダル形状記憶ポリマー |
| WO2008130954A2 (en) | 2007-04-19 | 2008-10-30 | Smith & Nephew, Inc. | Graft fixation |
| EP2152315B1 (en) | 2007-05-25 | 2016-01-06 | Indivior UK Limited | Sustained delivery formulations of risperidone compounds |
| JP2010529091A (ja) | 2007-06-06 | 2010-08-26 | インノテーレ・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 水硬性セメントをベースとするインプラント材料ならびにその使用 |
| US7678764B2 (en) | 2007-06-29 | 2010-03-16 | Johnson & Johnson Regenerative Therapeutics, Llc | Protein formulations for use at elevated temperatures |
| GB2451451A (en) * | 2007-07-30 | 2009-02-04 | Inion Ltd | Osteogenic compounds |
| US20100159011A1 (en) * | 2007-08-03 | 2010-06-24 | University Of Massachusetts Medical School | Compositions For Biomedical Applications |
| CN101801405A (zh) | 2007-08-07 | 2010-08-11 | 先进科技及再生医学有限责任公司 | 包含于酸性水溶液中的gdf-5的蛋白质配方 |
| US20110136935A1 (en) * | 2007-08-30 | 2011-06-09 | National University Of Singapore | Bone and/or dental cement composition and uses thereof |
| US20090061002A1 (en) * | 2007-09-05 | 2009-03-05 | Venbrocks Rudolf A | Calcium phospate based delivery of growth and differentiation factors to compromised bone |
| MX2010005004A (es) * | 2008-02-08 | 2010-05-27 | Colgate Palmolive Co | Composiciones y dispositivos. |
| BRPI0911048A2 (pt) | 2008-04-14 | 2015-12-29 | Atrm Llc | formulações líquidas tamponadas de gdf-5 |
| GB0813659D0 (en) * | 2008-07-25 | 2008-09-03 | Smith & Nephew | Fracture putty |
| CN202288967U (zh) * | 2008-11-19 | 2012-07-04 | 穆尼尔·萨洛芒 | 用于导向骨再生的阻隔物 |
| US20100226956A1 (en) * | 2009-03-06 | 2010-09-09 | Per Kjellin | Production of moldable bone substitute |
| AU2010330909B2 (en) | 2009-12-18 | 2014-09-11 | Howmedica Osteonics Corp. | Post irradiation shelf-stable dual paste direct injectable bone cement precursor systems and methods of making same |
| JP5669050B2 (ja) * | 2010-01-15 | 2015-02-12 | 国立大学法人島根大学 | 骨セメント |
| GB2481017B (en) | 2010-06-08 | 2015-01-07 | Rb Pharmaceuticals Ltd | Microparticle buprenorphine suspension |
| US9272044B2 (en) | 2010-06-08 | 2016-03-01 | Indivior Uk Limited | Injectable flowable composition buprenorphine |
| US8614190B2 (en) | 2010-06-30 | 2013-12-24 | Industrial Technology Research Institute | Thermal responsive composition for treating bone diseases |
| US10182973B2 (en) | 2010-11-10 | 2019-01-22 | Stryker European Holdings I, Llc | Polymeric bone foam composition and method |
| JP5890100B2 (ja) | 2011-02-09 | 2016-03-22 | 雪印メグミルク株式会社 | 皮膚コラーゲン産生促進剤 |
| EP2686027B1 (en) | 2011-03-16 | 2021-05-05 | Kuros Biosurgery AG | Pharmaceutical formulation for use in spinal fusion |
| KR101686683B1 (ko) * | 2011-07-15 | 2016-12-15 | 단국대학교 산학협력단 | 인산 칼슘 시멘트의 다공성 스캐폴드 제조방법 |
| US20140271769A1 (en) * | 2011-10-19 | 2014-09-18 | Innotere Gmbh | Preparation for the Manufacture of an Implant |
| US9539069B2 (en) * | 2012-04-26 | 2017-01-10 | Zimmer Dental, Inc. | Dental implant wedges |
| US9554877B2 (en) | 2012-07-31 | 2017-01-31 | Zimmer, Inc. | Dental regenerative device made of porous metal |
| CN103768657A (zh) * | 2012-10-24 | 2014-05-07 | 上海交通大学医学院附属第九人民医院 | 冻干海藻糖磷酸钙bmp-2缓释材料及其制备方法 |
| US10137223B2 (en) | 2013-03-14 | 2018-11-27 | Lifenet Health | Aligned fiber and method of use thereof |
| CN103272285B (zh) * | 2013-05-24 | 2014-12-03 | 华南理工大学 | 可全降解生物材料及其制备方法 |
| WO2015019600A1 (ja) * | 2013-08-06 | 2015-02-12 | クラレノリタケデンタル株式会社 | 生体硬組織修復用硬化性リン酸カルシウム組成物並びに骨修復材料及び各種歯科材料 |
| CN103467782B (zh) * | 2013-09-22 | 2015-08-19 | 山东力扬塑业有限公司 | 一种可生物降解的塑料及其制备方法 |
| CN103690991B (zh) * | 2013-12-17 | 2015-09-30 | 李克尊 | 一种软骨修复支架材料的制备方法 |
| GB201404139D0 (en) | 2014-03-10 | 2014-04-23 | Rb Pharmaceuticals Ltd | Sustained release buprenorphine solution formulations |
| WO2016140626A1 (en) * | 2015-03-04 | 2016-09-09 | Agency For Science, Technology And Research | Composite material for drug delivery |
| JP6976254B2 (ja) * | 2015-09-18 | 2021-12-08 | バイオネット ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツングBioNet Pharma GmbH | Cd−rap前駆体タンパク質の使用による、cd−rapの製造方法における発現およびフォールディングの改善 |
| CN106620883A (zh) * | 2016-12-09 | 2017-05-10 | 苏州艾博迈尔新材料有限公司 | 一种组织工程三维多孔支架及其制备方法 |
| JP2020520389A (ja) | 2017-05-16 | 2020-07-09 | エムボディ インコーポレイテッド | バイオポリマー組成物、足場及びデバイス |
| WO2018227293A1 (en) * | 2017-06-13 | 2018-12-20 | The University Of British Columbia | Polymeric paste compositions for drug delivery |
| AU2018354277B2 (en) | 2017-10-24 | 2024-09-26 | Embody Inc. | Biopolymer scaffold implants and methods for their production |
| RU2681916C1 (ru) * | 2017-11-22 | 2019-03-13 | Государственное бюджетное учреждение здравоохранения Московской области "Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского" (ГБУЗ МО МОНИКИ им. М.Ф. Владимирского) | Способ пластики дефектов трахеогортанного сегмента |
| CN107988302B (zh) * | 2018-01-23 | 2020-11-13 | 吉林省吉诺生物工程有限责任公司 | 一种鹿瓜多肽的制备方法及鹿瓜多肽在制备特殊医学用途食品中的应用 |
| CN108273131B (zh) * | 2018-03-19 | 2021-07-27 | 深圳市中科海世御生物科技有限公司 | 一种复合骨水泥、制备方法及其应用和一种骨修复材料 |
| EP3572102B1 (en) * | 2018-05-21 | 2021-02-24 | OssDsign AB | Two-paste cement-forming compositions |
| EP3861071A4 (en) | 2018-10-04 | 2022-07-20 | Fardanov, Aleksandra | Polyvinyl chloride-free lipophilic polymer based aromatized plastisol |
| MY203238A (en) | 2018-10-29 | 2024-06-19 | Fraunhofer Ges Zur Frderung Der Angewandten Forschung E V | Tetracycline complexes with sustained activity |
| EP3917756A4 (en) | 2019-02-01 | 2023-05-10 | Embody Inc. | Microfluidic extrusion |
| CN111110929B (zh) * | 2020-02-15 | 2020-12-22 | 深圳脉动医学技术有限公司 | 一种高生物安全性心脏支架及其制造方法 |
| CN111821513A (zh) * | 2020-08-14 | 2020-10-27 | 南方科技大学 | 一种促进软骨形成的复合水凝胶及其制备方法和应用 |
| CN116251235A (zh) * | 2022-12-14 | 2023-06-13 | 中国人民解放军空军军医大学 | 多孔骨引导/诱导自固化磷酸钙复合材料及其制备方法 |
| EP4599842A1 (en) * | 2024-02-09 | 2025-08-13 | Association Institut de Myologie | Pegylated gdf5 protein |
| CN119912274B (zh) * | 2025-04-07 | 2025-06-27 | 成都贝雅医疗科技有限公司 | 一种表面包覆改性的磷酸钙微球及其制备方法 |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0622567B2 (ja) * | 1986-12-16 | 1994-03-30 | 大日本塗料株式会社 | 医科用または歯科用セメント組成物 |
| US4938763B1 (en) | 1988-10-03 | 1995-07-04 | Atrix Lab Inc | Biodegradable in-situ forming implants and method of producing the same |
| US5702716A (en) | 1988-10-03 | 1997-12-30 | Atrix Laboratories, Inc. | Polymeric compositions useful as controlled release implants |
| US5487897A (en) | 1989-07-24 | 1996-01-30 | Atrix Laboratories, Inc. | Biodegradable implant precursor |
| US5324519A (en) | 1989-07-24 | 1994-06-28 | Atrix Laboratories, Inc. | Biodegradable polymer composition |
| DE4029969A1 (de) * | 1989-09-21 | 1991-04-04 | Asahi Optical Co Ltd | Verfahren zur herstellung von knochenprothesen |
| EP0470305A1 (en) * | 1990-08-07 | 1992-02-12 | Osteotech, Inc., | Osteoprosthetic implant |
| JPH0523388A (ja) * | 1991-07-18 | 1993-02-02 | Mitsubishi Materials Corp | リン酸カルシウムポーラスセメント |
| JP2686684B2 (ja) * | 1991-08-27 | 1997-12-08 | 寅雄 大塚 | 水酸化アパタイトを充填し生体内溶解性繊維により編機されたチューブ網編成物 |
| AU2605592A (en) | 1991-10-15 | 1993-04-22 | Atrix Laboratories, Inc. | Polymeric compositions useful as controlled release implants |
| US5281265A (en) * | 1992-02-03 | 1994-01-25 | Liu Sung Tsuen | Resorbable surgical cements |
| US5522893A (en) * | 1993-03-12 | 1996-06-04 | American Dental Association Health Foundation | Calcium phosphate hydroxyapatite precursor and methods for making and using the same |
| US5569468A (en) * | 1994-02-17 | 1996-10-29 | Modi; Pankaj | Vaccine delivery system for immunization, using biodegradable polymer microspheres |
| ATE317690T1 (de) | 1994-04-08 | 2006-03-15 | Qlt Usa Inc | Flüssige zusammensetzungen zur arzneistoffabgabe |
| AU1287895A (en) * | 1994-10-03 | 1996-04-26 | Otogen Corporation | Differentially biodegradable biomedical implants |
| US5764619A (en) * | 1995-04-07 | 1998-06-09 | Matsushita Electric Industrial Co., Ltd. | Optical recording medium having two separate recording layers |
| US5922253A (en) | 1995-05-18 | 1999-07-13 | Alkermes Controlled Therapeutics, Inc. | Production scale method of forming microparticles |
| US6132463A (en) * | 1995-05-19 | 2000-10-17 | Etex Corporation | Cell seeding of ceramic compositions |
| US5736152A (en) | 1995-10-27 | 1998-04-07 | Atrix Laboratories, Inc. | Non-polymeric sustained release delivery system |
| US20030211157A1 (en) * | 1996-05-06 | 2003-11-13 | Simon David Lew | Semi-sol delivery blend for water soluble molecules |
| EP0907721A1 (en) * | 1996-05-28 | 1999-04-14 | Brown University Research Foundation | Hyaluronan based biodegradable scaffolds for tissue repair |
| US6953594B2 (en) * | 1996-10-10 | 2005-10-11 | Etex Corporation | Method of preparing a poorly crystalline calcium phosphate and methods of its use |
| DE19647853A1 (de) | 1996-11-19 | 1998-05-20 | Bioph Biotech Entw Pharm Gmbh | Verbindungen mit verbesserter knorpel- und/oder knocheninduzierender Aktivität |
| JP4177900B2 (ja) * | 1997-04-04 | 2008-11-05 | 株式会社クラレ | 歯周病治療用材料 |
| DE19816858A1 (de) | 1998-04-16 | 1999-10-21 | Merck Patent Gmbh | Tricalciumphosphathaltige Biozementpasten mit Kohäsionspromotoren |
| US6143314A (en) | 1998-10-28 | 2000-11-07 | Atrix Laboratories, Inc. | Controlled release liquid delivery compositions with low initial drug burst |
| AU770196B2 (en) * | 1999-02-04 | 2004-02-12 | Warsaw Orthopedic, Inc. | Osteogenic paste compositions and uses thereof |
| WO2002032474A1 (en) * | 2000-10-13 | 2002-04-25 | Osteotech, Inc. | Method for inducing new bone growth in porous bone sites |
| US6461631B1 (en) | 1999-11-16 | 2002-10-08 | Atrix Laboratories, Inc. | Biodegradable polymer composition |
| US20030158302A1 (en) * | 1999-12-09 | 2003-08-21 | Cyric Chaput | Mineral-polymer hybrid composition |
| FR2805747B1 (fr) * | 2000-03-01 | 2003-03-14 | Teknimed | Procede de preparation d'un materiau pateux phosphocalcique injectable en vue de former un biomateriau apatitique et application chirurgicale ou dentaire |
| US20040018238A1 (en) * | 2001-02-26 | 2004-01-29 | Shukla Atul J | Biodegradable vehicles and delivery systems of biolgically active substances |
| US6949251B2 (en) * | 2001-03-02 | 2005-09-27 | Stryker Corporation | Porous β-tricalcium phosphate granules for regeneration of bone tissue |
| ATE303169T1 (de) | 2001-11-19 | 2005-09-15 | Scil Technology Gmbh | Homogen beschichtete vorrichtung mit osteoinduktiven und osteokonduktiven eigenschaften |
| US7166133B2 (en) * | 2002-06-13 | 2007-01-23 | Kensey Nash Corporation | Devices and methods for treating defects in the tissue of a living being |
| US20040109893A1 (en) * | 2002-06-25 | 2004-06-10 | Guohua Chen | Sustained release dosage forms of anesthetics for pain management |
| US6979352B2 (en) * | 2002-11-21 | 2005-12-27 | Depuy Acromed | Methods of performing embolism-free vertebroplasty and devices therefor |
| WO2004105825A1 (ja) * | 2003-01-10 | 2004-12-09 | Taki Chemical Co., Ltd. | 骨形成用生体材料、該材料を含む注入用製剤、及び該材料を調製するためのキット、並びにこれらを用いる骨形成方法 |
| CN1774220A (zh) * | 2003-02-14 | 2006-05-17 | 德普伊斯派尔公司 | 原位成型的椎间融合器械和方法 |
-
2004
- 2004-06-09 EP EP04013668A patent/EP1604693A1/en not_active Withdrawn
-
2005
- 2005-06-09 ES ES05751734T patent/ES2385212T3/es not_active Expired - Lifetime
- 2005-06-09 PT PT05751734T patent/PT1763374E/pt unknown
- 2005-06-09 EP EP10012828.9A patent/EP2322234B1/en not_active Expired - Lifetime
- 2005-06-09 CA CA2569744A patent/CA2569744C/en not_active Expired - Fee Related
- 2005-06-09 DK DK05751734.4T patent/DK1763374T3/da active
- 2005-06-09 PL PL05751734T patent/PL1763374T3/pl unknown
- 2005-06-09 WO PCT/EP2005/006204 patent/WO2005120595A2/en not_active Ceased
- 2005-06-09 JP JP2007526304A patent/JP4644252B2/ja not_active Expired - Fee Related
- 2005-06-09 US US11/629,119 patent/US20090048145A1/en not_active Abandoned
- 2005-06-09 EP EP05751734A patent/EP1763374B1/en not_active Expired - Lifetime
- 2005-06-09 ES ES10012828T patent/ES2429889T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP2322234B1 (en) | 2013-08-21 |
| EP1763374A2 (en) | 2007-03-21 |
| EP1604693A1 (en) | 2005-12-14 |
| ES2429889T3 (es) | 2013-11-18 |
| ES2385212T3 (es) | 2012-07-19 |
| EP2322234A1 (en) | 2011-05-18 |
| PL1763374T3 (pl) | 2012-10-31 |
| CA2569744A1 (en) | 2005-12-22 |
| PT1763374E (pt) | 2012-08-17 |
| WO2005120595A2 (en) | 2005-12-22 |
| WO2005120595A3 (en) | 2006-05-26 |
| JP4644252B2 (ja) | 2011-03-02 |
| JP2008501455A (ja) | 2008-01-24 |
| EP1763374B1 (en) | 2012-06-20 |
| CA2569744C (en) | 2011-03-15 |
| US20090048145A1 (en) | 2009-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1763374T3 (da) | Pasta, der hærder in situ, dens fremstilling og anvendelse | |
| NO2017017I1 (no) | umeklinidium og vilanterol | |
| DK1951885T3 (da) | Fructooligosaccharidfremstilling in situ og saccharosereduktion | |
| DK3498801T3 (da) | Sammensætninger med hfo-1234ze og hfc-134a | |
| DK2390267T3 (da) | Stabile og opløselige antistoffer, der hæmmer TNF(alfa) | |
| NO20055686L (no) | Sammensetning, fremgangsmate til fremstilling derav, og anvendelse derav. | |
| DK1969391T3 (da) | Tyndfilm emitter-absorber indretning og fremgangsmåde | |
| DK1954140T3 (da) | Glycerollevulinatketaler og deres anvendelse | |
| EP1945194A4 (en) | DENTAL AND ENDODONTIC FILLING MATERIALS AND METHOD | |
| DK1715893T3 (da) | Direkte kompressionsformulering og fremgangsmåde | |
| IS8204A (is) | Tæki og aðferð til að hluta niður | |
| NO2016020I2 (no) | Imidacloprid og Flumetrin | |
| DK1896364T3 (da) | Pulverformet kalksammensætning, fremgangsmåde til fremstilling deraf og anvendelse deraf | |
| DK2029799T3 (da) | Termostabile proteiner og fremgangsmåder til fremstilling og anvendelse heraf | |
| DE602005021959D1 (de) | Substituierte diazaspiroä4.5üdecanderivate und der | |
| DK1937276T3 (da) | Forbedret testosterongel og fremgangsmåde til anvendelse deraf | |
| DK2124997T3 (da) | Anvendelse af IL-1-antagonister til behandling af gigt og pseudogigt | |
| DK1817055T3 (da) | Ovr110-antistofsammensætninger og fremgangsmåder til anvendelse heraf | |
| DK1976548T3 (da) | VIP-fragmenter og sammensætninger deraf | |
| DE602006020156D1 (de) | Geschmackszusammensetzung oder duftzusammensetzung und geschmacksverbesserungsmittel | |
| DK1814977T3 (da) | Arthrospira-baserede sammensætninger og anvendelser deraf | |
| DK1885716T3 (da) | Thiazolderivater og anvendelse deraf | |
| DK1955484T3 (da) | Hjemmenetværksapplikation, der anvender trådbaserede og trådløse sikre forbindelser | |
| DK1954713T3 (da) | Modificerede grønfluorescerende proteiner og fremgangsmåder til anvendelse af samme | |
| DK1783105T3 (da) | Mørtelsammensætning, fremgangsmåde til fremstilling og anvendelse deraf |